|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Heparin-induced thrombocytopenia 显示文摘 | Bambrah RK Pham DC Zaiden R | 2011 | Clin Adv Hematol Oncol2011，9，8： | 1 |
| 2 | Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer显示文摘AIM To review surgical outcomes for patients undergoing pancreatectomy after proton therapy with concomitant capecitabine for initially unresectable pancreatic adenocarcinoma.METHODS From April 2010 to September 2013,15 patients with initially unresectable pancreatic cancer were treated withproton therapy with concomitant capecitabine at 1000 mg orally twice daily. All patients received 59.40 Gy(RBE) to the gross disease and 1 patient received 50.40 Gy(RBE) to high-risk nodal targets. There were no treatment interruptions and no chemotherapy dose reductions. Six patients achieved a radiographic response sufficient to justify surgical exploration,of whom 1 was identified as having intraperitoneal dissemination at the time of surgery and the planned pancreatectomy was aborted. Five patients underwent resection. Procedures included:Laparoscopic standard pancreaticoduodenectomy(n = 3),open pyloris-sparing pancreaticoduodenectomy(n = 1),and open distal pancreatectomy with irreversible electroporation(IRE) of a pancreatic head mass(n = 1). RESULTS The median patient age was 60 years(range,51-67). The median duration of surgery was 419 min(range,290-484),with a median estimated blood loss of 850 cm^3(range,300-2000),median ICU stay of 1 d(range,0-2),and median hospital stay of 10 d(range,5-14). Three patients were re-admitted to a hospital within 30 d after discharge for wound infection(n = 1),delayed gastric emptying(n = 1),and ischemic gastritis(n = 1). Two patients underwent R0 resections and demonstrated minimal residual disease in the final pathology specimen. One patient,after negative pancreatic head biopsies,underwent IRE followed by distal pancreatectomy with no tumor seen in the specimen. Two patients underwent R2 resections. Only 1 patient demonstrated ultimate local progression at the primary site. Median survival for the 5 resected patients was 24 mo(range,10-30).CONCLUSION Pancreatic resection for patients with initially unresectable cancers is feasible after high-dose [59.4 Gy(RBE)] proton radiotherapy with a high rate of local control,acceptable surgical morbidity,and a median survival of 24 mo. | Kathryn E Hitchcock R Charles Nichols Christopher G Morris Debashish Bose Steven J Hughes John A Stauffer Scott A Celinski Elizabeth A Johnson Robert A Zaiden Nancy P Mendenhall Michael S Rutenberg | 2017 | World Journal of Gastrointestinal Surgery2017，9，4： | 1 |
| 3 | Characterization of a side populalion of astrocytoma cells in response totemozolomide 显示文摘 | Chua C Zaiden N Chong KH | 2008 | J Neurosurg2008，109，5： | 1 |
| 4 | Idl, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells显示文摘 | Yap WN Zaiden N Tan YL | 2010 | Cancer Lett2010，291，2： | 1 |
| 5 | Breast cancer and racial disparity between Caucasian and African American women, part 1 (BRCA-1) 显示文摘 | Tariq K Latif N Zaiden R | 2013 | Clin Adv Hematol Oneol2013，11，8： | 1 |
| 6 | Idl, inhibitor of differentiation, is a key protein mediating anti - tumor responses of gamma - tocot- rienol in breast cancer cells 显示文摘 | Yap WN Zaiden N Tan YL | 2010 | Cancer Lett2010，291，2： | 1 |
| 7 | Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study显示文摘 | Hoppe BS Flampouri S Zaiden R | 2014 | Int J Radiat Oncol Biol Phys2014，89，5： | 1 |
| 8 | Characterization of a side population of astrocytoma cells in response to temozolomide显示文摘 | Chua C Zaiden N Chong KH | 2008 | J Neurosurg2008，109，85： | 1 |
| 9 | Surgical treatment andadjuvant therapies of recurrent respiratory papillomatosis 显示文摘 | Avelino MA Zaiden TC Gomes RO | 2013 | Braz JOtorhinolaryngol2013，79，5： | 1 |
| 10 | Characterization of side pop- ulation of astrocytoma ceils in response to temozolomide 显示文摘 | Chua C Zaiden N Chong KH | 2008 | J Neuro Surg2008，109，5： | 1 |
| 11 | Characterization of a side population of astrocytoma ceils in response to temo- zolomide显示文摘 | Chua C Zaiden N Chong KH | 2008 | J Neurosurg2008，109，5： | 1 |
| 12 | Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity显示文摘 | R. Charles Nichols Thomas J. George Robert A. Zaiden Ziad T. Awad Horacio J. Asbun Soon Huh Meng Wei Ho Nancy P. Mendenhall Christopher G. Morris bradford S. Hoppe | 2013 | Acta Oncologica2013，，3： | 1 |
| 13 | Idl, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells 显示文摘 | YAP W N ZAIDEN N TAN Y L | 2010 | Cancer Lett2010，291，2： | 1 |
| 14 | Detection of thyroid peroxidase mRNA and protein in orbital tissue 显示文摘 | Lai O F Zaiden N Goh S S | 2006 | Eur J Endocrinol2006，155，2： | 1 |
| 15 | Characterization of a side population of astrocytoma cells in response to temozolomide显示文摘 | Chua C Zaiden N Chong KH | 2008 | J Neurosurg2008，109，5： | 1 |
| 16 | Sur- gical treatment and adjuvant therapies of recurrent re- spiratory papillomatosis显示文摘 | AVELINO M A ZAIDEN T C GOMES R O | 2013 | Braz J Otorhinolaryngol2013，79，： | 1 |
| 17 | Id I, inhibitor of differentiation, is a key protein mediating an- ti-tumor responses of gamma-tocotrienol in breast cancer cells 显示文摘 | Yap WN Zaiden N Tan YL Ngoh CP Zhang XW Wong YC el al | 2010 | Canc Lett2010，291，2： | 1 |
| 18 | Characterization of a side population of astrocytoma ceils in response to temozolomide 显示文摘 | Chua C Zaiden N Chong KH | 2008 | J Neurosurg2008，109，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员